CLINICAL_TRIALS
trial_result
· 2020-08-26
Clinical Trial Update: TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]
Summary
Phase 3 trial update for TRI102 in children with ADHD has completed and results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tris Pharma, Inc. | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 3 | Status: COMPLETED | Results posted: 2020-08-26